	Press Release: Sarclisa recommended for EU approval by the - GlobeNewswire
	FDA Approves Merck’s Enflonsia as Rival to Sanofi and AstraZeneca’s Beyfortus in RSV Prevention Market - geneonline.com
	Sanofi, Regeneron Get FDA Approval for Dupixent to Treat Rare Skin Disease - WSJ
	Digital and AI Powered Manufacturing ' Supply: Delivering Faster and Safer for Patients - Sanofi
	Ventyx posts phase 2 Parkinson's data ahead of potential talks with Sanofi - Fierce Biotech
	BIO2025: Sanofi R'D, FDA's Martin Makary, Paying For New Therapies - Life Science Leader
	Sanofi: positive opinion from CHMP for multiple myeloma - MarketScreener
	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY - PR Newswire